Lyons Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-28,626
Closed -$873K 91
2014
Q1
$873K Buy
28,626
+6,645
+30% +$198K 0.76% 16
2013
Q4
$639K Buy
+21,981
New +$640K 0.6% 17

Other funds holding PFE

Lyons Wealth Management's PFE Position: Q2 2014 in Review

Lyons Wealth Management sold out of Pfizer (PFE) in Q2 2014, closing a stake of 28,626 shares — an estimated $873K sold.

Lyons Wealth Management first reported a position in PFE in Q4 2013 and held it in 2 quarters. The position peaked at $873K in Q1 2014. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Lyons Wealth Management reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
  • Lyons Wealth Management sold 28,626 Pfizer shares in Q2 2014, an estimated $873K.
  • Lyons Wealth Management first reported a position in Pfizer in Q4 2013 and held it in 2 quarters.
  • Lyons Wealth Management's Pfizer position peaked at $873K in Q1 2014.
  • 1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Lyons Wealth Management's 13F filing for Q2 2014, filed 11 Aug 2014.